Eden Research’s biofungicide 3AEY got label extensions in Spain and Greece

Eden Research plc (EDEN) recently announced that, together with its commercialisation partners in Spain (Sipcam Iberia) and Greece (Redestos Group), it has been granted label extensions for the use of 3AEY for a new disease target in Spain and number of additional minor uses in Greece, beyond the original designation for the prevention and treatment of botrytis in table and wine grapes.

In Spain, 3AEY (locally marketed as “ARAW” by Sipcam) has been additionally approved for use in the control of vine powdery mildew. Powdery mildew is one of the most challenging and widespread fungal diseases of grapevines in the world. Powdery mildew manifests itself as a powdery growth on the tissue of the vine and affects both table grapes and wine grapes causing significant crop losses and impacting the quality of wine. In Greece, the authorities have expanded the approval for the use of 3AEY (marketed as Mevalone in Greece and the Balkan states) in the treatment of botrytis on field and greenhouse aubergines, kiwis, pomegranates and fresh onions.  Combined, these crops cover more than 14,000 hectares in Greece. 
 
These approvals are the first milestone in the expansion of regulatory clearance for 3AEY outside of the initial authorisation for the prevention and cure of botrytis on table and wine grapes.  Together with Redestos Group, Eden is also pursuing authorisation for 3AEY in several countries outside of the EU Southern Zone, and these registrations will be granted in due course, subject to regulatory process and approval.